Galatek, a rapidly growing Singapore-based automation and artificial intelligence (AI) startup, has secured approximately US$30 million in Series A funding. This funding will enable the company to accelerate the development of innovative products in the life sciences and advanced semiconductor manufacturing sectors, strengthen its global supply chain, and deepen its local expertise in key markets across Europe, North America, and Southeast Asia.
As AI continues to accelerate digital transformation across all sectors, Galatek is addressing critical challenges in the life sciences and semiconductor manufacturing industries. The company delivers automation and AI solutions that are reshaping smart labs and advanced packaging—key sectors where precision and intelligence define the next generation of innovation.
Based in Singapore’s innovation hub, Galatek combines its agile, globally connected R&D with a localized commercial presence in strategic markets, positioning itself as a vital catalyst for industrial progress in the AI era.
Galatek is strategically focusing on two high-demand markets where significant technological gaps remain:
In life sciences
The company is pioneering the smart lab of the future. By deeply integrating AI into research and development and services workflows, Galatek empowers scientists to accelerate and reduce the risks of discovery in complex applications, including diagnostics, next-generation sequencing (NGS), 3D cell and organoid culture, drug development, and synthetic biology. This is further enhanced by Galatek’s Abio software platform, an integrated, AI-driven solution that unifies the lab laptop (ELN), laboratory information management system (LIMS), science data management system (SDMS), and advanced automation to transform scientific data into actionable insights, streamline robotic integrations, and support customizable, cloud-agnostic smart lab operations through its extensible architecture.
Galatek has forged strategic partnerships with leading pharmaceutical companies and research institutes and has co-created next-generation smart labs with world-renowned academic partners such as the National University of Singapore, thereby establishing a pipeline for sustainable technological leadership.
In semiconductors
Galatek also focuses on AI-driven innovation and implementation for advanced packaging. Through deep integration of AI vision and motion control algorithms, the company meets extreme demands for accuracy and reliability. It provides equipment and solutions for critical processes, from upstream metrology and inspection to downstream advanced packaging. Core solutions include fully automated overlap measurement systems, deep learning-based automated optical inspection (AOI) systems, and precision wafer slicing equipment. Galatek currently collaborates with several leading global semiconductor manufacturers, demonstrating its end-to-end go-to-market capabilities, from technological breakthrough to large-scale delivery.
Galatek’s business model, “Global Supply Chain + Localized Service,” combines the competitive advantages of Asian supply chains with company-owned delivery centers in Malaysia and the United States, creating a resilient global logistics network. In key markets, local teams in Europe, North America, and Southeast Asia provide proactive and personalized support throughout the customer journey, from sales and technical service to compliance, ensuring customers benefit from a comprehensive, integrated offering.
“The global industry is undergoing a fundamental transformation, driven by artificial intelligence and automation,” said David Tian, CEO of Galatek . “The need for smart labs in the life sciences and the imperative for innovation in advanced semiconductor packaging are not just industry needs—they are critical moments that demand our full attention. Galatek’s mission is to be a trusted infrastructure partner in this transformation. By combining world-class supply chain capabilities with local resources, we are confident in delivering the innovative solutions that international customers require—solutions that traditional suppliers often struggle to deploy quickly. This Series A funding allows us to accelerate our journey to fulfilling this role at scale.”
